Echo IQ Taps Industry Vet for U.S. Market Growth

EchoIQ Limited (AU:EIQ) has released an update.

Echo IQ Limited has appointed seasoned healthcare executive Dustin Haines as CEO, bringing over 25 years of industry experience to lead the company’s commercialization efforts in the US market. Haines’ prior roles include VP & General Manager at Gilead Sciences and senior positions at ViiV Healthcare and GSK, providing him with a strong track record for driving commercial success. His appointment is timely as Echo IQ advances negotiations with key healthcare groups and manufacturers for its AI-driven technology, EchoSolv.

For further insights into AU:EIQ stock, check out TipRanks’ Stock Analysis page.